Get 20% lifetime commission for referring investors to digrin.com
here.
Generate Biomedicines, Inc. ( GENB) - Stock Earnings
GENB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
GENB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -52.4 million USD | 10.1 million USD |
| 2026Q1 | -61.4 million USD | 7.2 million USD |
| 2026Q2 | -67.3 million USD | 6.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GENB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -173.8 million USD | 20.5 million USD |
| 2025 | -203.2 million USD | 31.9 million USD |
| 2026 Est. | — | — |
GENB
Price: $12.09
52 week price:
Earnings Per Share: -2.10 USD
Exchange: NGM
Sector: Financial Services
Industry: Asset Management
Market Capitalization: 1.8 billion